![]() |
Volumn 75, Issue 5, 2001, Pages 2324-2330
|
Infectivity-enhancing antibodies to Ebola virus glycoprotein
a
a
a
a
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY;
EBOLA VACCINE;
EPITOPE;
GLYCOPROTEIN;
GLYCOPROTEIN ANTIBODY;
MONOCLONAL ANTIBODY;
UNCLASSIFIED DRUG;
VIRUS PROTEIN;
VIRUS VACCINE;
ANTIBODY DEPENDENT ENHANCEMENT;
ARTICLE;
COMPLEMENT SYSTEM;
CONTROLLED STUDY;
EBOLA VIRUS;
FEMALE;
IMMUNIZATION;
MORTALITY;
MOUSE;
NONHUMAN;
PATHOGENICITY;
PLASMID;
PRIORITY JOURNAL;
PROPHYLAXIS;
STRAIN DIFFERENCE;
VIRUS HEMORRHAGIC FEVER;
VIRUS VIRULENCE;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, VIRAL;
ANTIBODY-DEPENDENT ENHANCEMENT;
CELL LINE;
EBOLAVIRUS;
EPITOPES;
GLYCOPROTEINS;
HUMANS;
IMMUNIZATION;
MEMBRANE GLYCOPROTEINS;
MICE;
MICE, INBRED BALB C;
NEUTRALIZATION TESTS;
SPECIES SPECIFICITY;
VACCINES, DNA;
VESICULAR STOMATITIS-INDIANA VIRUS;
VIRAL PROTEINS;
VIRULENCE;
|
EID: 0035121346
PISSN: 0022538X
EISSN: None
Source Type: Journal
DOI: 10.1128/JVI.75.5.2324-2330.2001 Document Type: Article |
Times cited : (105)
|
References (29)
|